Betahistine Hydrochloride

CAS 5579-84-0 9 current recordsSmall Molecule

Who holds supplier records for Betahistine Hydrochloride? 9 organisations hold a current record for Betahistine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), Italy (1), Germany (1) and Spain (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Betahistine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/betahistine-hydrochloride

Reading the evidence

  • 9 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    5 of the 8 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (9)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Betahistine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India5Italy1Germany1Spain1Country not recorded for 1
Need Betahistine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Betahistine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam VillageIN
CEP 2025-260 - Rev 00
Betahistine dihydrochloride
Sept 2026—
Grunenthal GmbH AachenDE
CEP 2009-001 - Rev 03
Betahistine dihydrochloride
Oct 2025Inspected Nov 2024
Germany
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2022-505 - Rev 02
Betahistine dihydrochloride
Sept 2025—
Laboratorios Espinos Y Bofill S.A. Cornella de LlobregatES
CEP 2009-177 - Rev 03
Betahistine dihydrochloride
Dec 2024Inspected Apr 2023
Spain, outside 3-year window
AMI LIFESCIENCES PRIVATE LIMITED KarakhadiIN
CEP 2011-101 - Rev 04
Betahistine dihydrochloride
Jul 2024Inspected Oct 2025
Slovakia
COHANCE LIFESCIENCES LIMITED MumbaiIN
CEP 2013-240 - Rev 02
Betahistine dihydrochloride
Jul 2024—
OLON S.P.A. RodanoIT
CEP 2006-316 - Rev 05
Betahistine dihydrochloride
Jul 2024Inspected Mar 2025
Italy
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2012-058 - Rev 01
Betahistine dihydrochloride
Nov 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Betahistine Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1446813).

Chemical identity

IUPAC name
N-methyl-2-pyridin-2-ylethanamine;dihydrochloride
Canonical SMILES
CNCCC1=CC=CC=N1.Cl.Cl
InChIKey
XVDFMHARQUBJRE-UHFFFAOYSA-N
Synonyms
Betahistine dihydrochloride, Betahistine hcl, Betahistine hydrochloride, NSC-757397, PT-9, Serc-16, Serc-8, Serc, Betaserc, RefChem:567992, Betahistine 2HCl, Microser

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Betahistine Hydrochloride?

9 organisations hold an active US FDA Type II Drug Master File or a CEP for Betahistine Hydrochloride: Maithri Laboratories Private Limited (India), OLON SPA (Italy), HENAN PURUI PHARMACEUTICAL CO LTD, AMI LIFESCIENCES PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), COHANCE LIFESCIENCES LTD (India), Grünenthal GmbH (Germany) and MATRIX PHARMACORP PRIVATE LTD (India), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Betahistine Hydrochloride Drug Master Files are active?

Maithri Laboratories Private Limited (DMF 41583), OLON SPA (DMF 19495) and HENAN PURUI PHARMACEUTICAL CO LTD (DMF 36103). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Betahistine Hydrochloride have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Betahistine Hydrochloride on the EDQM register, including MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village (IN), Grunenthal GmbH Aachen (DE), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), Laboratorios Espinos Y Bofill S.A. Cornella de Llobregat (ES), AMI LIFESCIENCES PRIVATE LIMITED Karakhadi (IN) and COHANCE LIFESCIENCES LIMITED Mumbai (IN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Betahistine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Betahistine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.